We’re moving! Effective Monday, April 22, 2024, the Goulston & Storrs Boston Office will be located at One Post Office Square, 25th Floor, Boston, MA 02109. Telephone numbers will remain the same. Close Banner

Clinical Development Oncology Company Series B-1 Preferred Stock and Warrants

Represented a venture-backed, late-stage clinical development oncology company focused on an epigenetic approach to overcoming the problem of resistance in cancer therapy in connection with its private placement of Series B-1 Preferred Stock and warrants; Represented company in connection with its private placement of Series B-1 Preferred Stock to an Asian venture capital firm; Represented company with its private placement of Series B-1 Preferred Stock to a Russian sovereign wealth backed private equity investor, and current investors; Represented company in connection with several convertible note financing transactions.